Vancelian research
Access free, institutional-grade market analyses designed by our in-house financial market experts, available directly on our platform or through our mobile app. Based on rigorous approaches such as Elliott waves, fractal and harmonic analysis, and traditional charting techniques, our technical studies provide exclusive and detailed insights into digital assets, empowering you to make informed decisions in a domain typically reserved for insiders.
BTC/USDC - (Target Reached) BTC reached 67 000 and remains in trading range
30 July 2024
RUNE/USDC - (Target Reached - new analysis coming soon) 3,60 Tactical support penetrated - Alternative scenario confirmed
18 July 2024
FTT/USDC - (Target Reached - new analysis coming soon) (High Risk Warning) 1,30 Tactical support penetrated - Alternative scenario confirmed
17 July 2024
BCH/USDC - (UPDATE) 340 Tactical support penetrated - Alternative scenario confirmed
15 July 2024
AAVE/USDC - (Target Reached - new analysis coming soon) 89 Tactical support penetrated - Alternative scenario confirmed
15 July 2024
PEPE/USDC - (Target reached - new analysis coming soon) 0.0000065 Tactical support penetrated - Alternative scenario confirmed
11 July 2024
FET/USDC - (UPDATE) 0,99 Tactical support penetrated - Alternative scenario confirmed
11 July 2024
SOL/USDC - (Target Reached) In progress within a consolidation pattern before recovery
11 July 2024
YGG/USDC - (UPDATE) 0,3130 Tactical support penetrated - Alternative scenario confirmed
11 July 2024
AKTIO/USDC - AKTIO is evolving without clear trend signal now.
03 July 2024
BTC/USDC - (Target Reached) BTC is evolving in trading range with no clear direction
24 June 2024
ETH/USDC - (Support Reached) ETH is evolving in trading range with no clear direction
24 June 2024
AKTIO/USDC - (BUY) AKTIO recovery engaged towards 1,03 a head of MICA Licence
24 May 2024
BTC/USDC - (Target Reached) BTC progressing in range with bullish exit pre-signal
21 May 2024
ETH/USDC - (Target Reached) No clear directional view between 3140 and 3510
13 May 2024
The views and opinions expressed herein are those of the author(s) and do not necessarily reflect the views of Vancelian and summarizes information and articles with respect to cryptocurrencies or related topics. This material is for informational purposes only and is only intended for sophisticated investors, and is not (i) an offer, or solicitation of an offer, to invest in, or to buy or sell, any interests or shares, or to participate in any investment or trading strategy, (ii) intended to provide accounting, legal, or tax advice, or investment recommendations, or (iii) an official statement of Vancelian. No representation or warranty is made, expressed or implied, with respect to the accuracy or completeness of the information or to the future performance of any digital asset, financial instrument or other market or economic measure. The information is believed to be current as of the date indicated and may not be updated or otherwise revised to reflect information that subsequently became available or a change in circumstances after the date of publication. Vancelian, its affiliates and its employees do not make any representation or warranty, expressed or implied, as to accuracy or completeness of the information or any other information transmitted or made available. Investing in cryptocurrency comes with risk. Certain statements in this document provide predictions and there is no guarantee that such predictions are currently accurate or will ultimately be realized. Prior results that are presented here are not guaranteed and prior results do not guarantee future performance. Recipients should consult their advisors before making any investment decision.
Certain links that may be provided in the materials are provided for convenience and do not imply Vancelian's endorsement, or approval of any third-party websites or their content. Any use, review, retransmission, distribution, or reproduction of these materials, in whole or in part, is strictly prohibited in any form without the express written approval of Vancelian.